| Ident. | Authors (with country if any) | Title |
|---|
| 000045 (2020) |
Lila Bouadma [France] ; Francois-Xavier Lescure [France] ; Jean-Christophe Lucet [France] ; Yazdan Yazdanpanah [France] ; Jean-Francois Timsit [France] | Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists |
| 000122 (2014) |
Valerie November [France] ; Yvan Leanza | Centralising Information: Predicting and Managing the Risk of Pandemics at the WHO |
| 000192 (2020) |
Bo Xu [République populaire de Chine, Royaume-Uni] ; Bernardo Gutierrez [Royaume-Uni, Équateur] ; Sumiko Mekaru [États-Unis] ; Kara Sewalk [États-Unis] ; Lauren Goodwin [États-Unis] ; Alyssa Loskill [États-Unis] ; Emily L. Cohn [États-Unis] ; Yulin Hswen [États-Unis] ; Sarah C. Hill [Royaume-Uni] ; Maria M. Cobo [Équateur, Royaume-Uni] ; Alexander E. Zarebski [Royaume-Uni] ; Sabrina Li [Royaume-Uni] ; Chieh-Hsi Wu [Royaume-Uni] ; Erin Hulland [États-Unis] ; Julia D. Morgan [États-Unis] ; Lin Wang [France, Royaume-Uni] ; Katelynn O Rien [États-Unis] ; Samuel V. Scarpino [États-Unis] ; John S. Brownstein [États-Unis] ; Oliver G. Pybus [Royaume-Uni] ; David M. Pigott [États-Unis] ; Moritz U. G. Kraemer [Royaume-Uni, États-Unis] | Epidemiological data from the COVID-19 outbreak, real-time case information |
| 000269 (2004) |
X. W. Zhang [République populaire de Chine] ; Y. L. Yap [République populaire de Chine] ; A. Danchin [France] | Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus |
| 000270 (2003) |
Yee Leng Yap [Hong Kong] ; Xue Wu Zhang [Hong Kong] ; Antoine Danchin [France] | Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling |
| 000284 (2003) |
Tuen Wai Ng [République populaire de Chine] ; Gabriel Turinici [France] ; Antoine Danchin [France] | A double epidemic model for the SARS propagation |
| 000308 (2007) |
Vittoria Colizza [Italie] ; Alain Barrat [Italie, France] ; Marc Barthélemy [France] ; Alessandro Vespignani [États-Unis, Italie] | Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study |
| 000334 (2015) |
F. Rodhain [France] | Bats and Viruses: complex relationships |
| 000447 (2003) |
Rustom Antia [États-Unis] ; Roland R. Regoes [États-Unis] ; Jacob C. Koella [France] ; Carl T. Bergstrom [États-Unis] | The role of evolution in the emergence of infectious diseases |
| 000507 (2018) |
Rose Bernard [Royaume-Uni] ; G. Bowsher [Royaume-Uni] ; C. Milner [Royaume-Uni] ; P. Boyle [France] ; P. Patel [Royaume-Uni] ; R. Sullivan [Royaume-Uni] | Intelligence and global health: assessing the role of open source and social media intelligence analysis in infectious disease outbreaks |
| 000743 (2004) |
Marie-Pierre Egloff [France] ; François Ferron [France] ; Valérie Campanacci [France] ; Sonia Longhi [France] ; Corinne Rancurel [France] ; Hélène Dutartre [France] ; Eric J. Snijder [Pays-Bas] ; Alexander E. Gorbalenya [Pays-Bas] ; Christian Cambillau [France] ; Bruno Canard [France] | The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world |
| 000825 (2020) |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000827 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000984 (2009) |
Inca C. Kusters [France] ; James Matthews [États-Unis] ; Jean François Saluzzo [France] | Manufacturing Vaccines for an Emerging Viral Infection–Specific Issues Associated with the Development of a Prototype SARS Vaccine |
| 000A11 (2004) |
N. Postel-Vinay [France] ; J. Chemardin [France] | La communication sur le SRAS : un outil essentiel de santé publique |
| 000A21 (2020) |
Didier Raoult [France] ; Alimuddin Zumla [Royaume-Uni] ; Franco Locatelli [Italie] ; Giuseppe Ippolito [Italie] ; Guido Kroemer [France] | Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |
| 000A22 (????) |
Didier Raoult [France] ; Alimuddin Zumla [Royaume-Uni] ; Franco Locatelli [Italie] ; Giuseppe Ippolito [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède] | Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |
| 000A36 (2020) |
Wen-Chien Ko [Taïwan] ; Jean-Marc Rolain [France] ; Nan-Yao Lee [Taïwan] ; Po-Lin Chen [Taïwan] ; Ching-Tai Huang [Taïwan] ; Ping-Ing Lee [Taïwan] ; Po-Ren Hsueh [Taïwan] | Arguments in favour of remdesivir for treating SARS-CoV-2 infections |
| 000A37 (2020) |
Philippe Colson [France] ; Jean-Marc Rolain [France] ; Didier Raoult [France] | Chloroquine for the 2019 novel coronavirus SARS-CoV-2 |
| 000A88 (2020) |
Philippe Colson [France] ; Bernard La Scola [France] ; Vera Esteves-Vieira [France] ; Laetitia Ninove [France] ; Christine Zandotti [France] ; Marie-Thérèse Jimeno [France] ; Céline Gazin [France] ; Marielle Bedotto [France] ; Véronique Filosa [France] ; Audrey Giraud-Gatineau [France] ; Hervé Chaudet [France] ; Philippe Brouqui [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2 |
| 000A89 (2020) |
Chantal B. Reusken [Pays-Bas] ; Bart Haagmans [Pays-Bas] ; Adam Meijer [Pays-Bas] ; Victor M. Corman [Allemagne] ; Anna Papa [Grèce] ; Remi Charrel [France] ; Christian Drosten [Allemagne] ; Marion Koopmans [Pays-Bas] | Authors’ response: Plenty of coronaviruses but no SARS-CoV-2 |
